ADBE 241213 532.50P (ADBE241213P532500) Stock Options, News & Quotes - Moomoo

US OptionsDetailed Quotes

ADBE241213P532500

Watchlist

74.02
+15.88+27.31%

15min DelayClose Dec 13 16:00 ET

74.02High64.10Low

Intraday

5D
Daily

News

Trending Stocks Amid a Mixed Week for U.S. Stock Market
Seeking Alpha12:08 ET
Notable Analyst Calls This Week: AMD, Adobe and Utilities Stocks Among Top Picks
Seeking AlphaDec 14 09:37 ET
Four Out of Six Companies Deliver EPS Wins This Week - Earnings Scorecard
Seeking AlphaDec 14 08:27 ET
Microsoft, Meta Among Leaders in Monetizing GenAI Heading Into 2025: Mizuho
Seeking AlphaDec 14 08:00 ET
Adobe Options Spot-On: On December 13th, 205.19K Contracts Were Traded, With 465.75K Open Interest
Moomoo NewsDec 13 16:30 ET
Weekly Buzz: Tech stocks hit high scores on ominous day
Kevin TraversDec 13 16:29 ET

Comments

This $2.25 Stock Soon To Turn A Profit Is Highly Likely To Be Acquired Above $10

This unique biotech $Esperion Therapeutics (ESPR.US)$ Esperion has the only FDA approved statin alternative drugs NEXLIZET & NEXLETOL for Primary Prevention, Statins are a class of prescription drugs that help lower cholesterol levels. They are the most common treatment for high cholesterol, an estimated 21 Million Americans are Statin intolerant and or maxed out on Statin drugs and need additional lowering. Over 71 ...

This $2.25 Stock Soon To Turn A Profit Is Highly Likely To Be Acquired Above $10

This $2.25 Stock Soon To Turn A Profit Is Highly Likely To Be Acquired Above $10

This $2.25 Stock Soon To Turn A Profit Is Highly Likely To Be Acquired Above $10

+2

2

1

1

Must BUY Esperion Therapeutics Selling FDA Approved Statin Alternative Drugs Will Soon Be Acquired Suspect The Analysts.

This unique biotech $Esperion Therapeutics (ESPR.US)$ Esperion has the only FDA approved statin alternative drugs NEXLIZET & NEXLETOL for Primary Prevention, Statins are a class of prescription drugs that help lower cholesterol levels. They are the most common treatment for high cholesterol, an estimated 21 Million Americans are Statin intolerant and or maxed out on Statin drug...

Must BUY Esperion Therapeutics Selling FDA Approved Statin Alternative Drugs Will Soon Be Acquired Suspect The Analysts.

Must BUY Esperion Therapeutics Selling FDA Approved Statin Alternative Drugs Will Soon Be Acquired Suspect The Analysts.

Must BUY Esperion Therapeutics Selling FDA Approved Statin Alternative Drugs Will Soon Be Acquired Suspect The Analysts.

+2

1

Yesterday 05:40

$Adobe (ADBE.US)$ The OI put/call ratio has dropped considerably. It being under 1 could mean good news for next week.

1

2

Yesterday 03:03

$Adobe (ADBE.US)$ shud sell you before earning. Lousy shit

2

Yesterday 03:00

$Adobe (ADBE.US)$ earnings where great did they have bac giudence ? why down

1

1

Read more